Predictive Oncology Inc (POAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 1,412 | 1,412 | 655 | 457 | 654 |
| Cost of Goods | 532 | 416 | 148 | 182 | 304 |
| Gross Profit | 880 | 996 | 507 | 275 | 350 |
| Operating Expenses | 15,186 | 9,273 | 6,708 | 6,983 | 5,054 |
| Operating Income | -13,775 | -7,861 | -6,054 | -6,526 | -4,400 |
| Interest Expense | 0 | 0 | 0 | 0 | 391 |
| Other Income | -5,616 | -2,225 | 51 | 0 | 0 |
| Pre-tax Income | -19,391 | -10,087 | -6,003 | -6,526 | -4,791 |
| Net Income Continuous | -19,391 | -10,087 | -6,003 | -6,526 | -4,791 |
| Net Income | $-19,391 | $-10,087 | $-6,003 | $-6,526 | $-4,791 |
| EPS Basic Total Ops | -2,056.97 | -2,359.82 | -2,818.59 | -6,926.54 | -92,533.74 |
| EPS Basic Continuous Ops | -2,025.90 | -2,359.83 | -2,828.87 | -6,931.73 | -92,673.59 |
| EPS Diluted Total Ops | -2,056.97 | -2,359.82 | -2,818.59 | -6,926.54 | -92,533.74 |
| EPS Diluted Continuous Ops | -2,025.90 | -2,359.83 | -2,828.87 | -6,931.73 | -92,673.59 |
| EPS Diluted Before Non-Recurring Items | -1,259.37 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-11,046 | $-7,329 | $-5,982 | $-6,444 | $-4,102 |